CHEK2 and gastric cancer: Although the CHEK2 inhibitor and ATR inhibitor are not currently approved for gastric cancer, previous studies reported that proliferations of gastric cancer cell lines were suppressed by a CHEK inhibitor 39 and an ATR inhibitor 40.